Clinical Trials List
Protocol NumberTYR430-101
Active
2025-03-31 - 2028-05-06
Phase I
Recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Hung-Yuan Yu 無
- 李癸汌 無
- Yi-Ping Hung 無
- San-Chi Chen 無
- Yi-Hsiang Huang 無
- Chun-Yu Liu 無
- Chueh-Chuan Yen 無
- 吳紋綺 Division of Hematology & Oncology
- 唐振育 無
- Tien-Hua Chen 無
- Muh-Hwa Yang 無
- Hao-Wei Teng 無
- 呂學聖 無
- 姜乃榕 無
- Shao-Jung Hsu 無
- 陳宥任 無
- 齊振達 無
- Yun-Cheng Hsieh 無
- 吳啟榮 無
- I-Cheng Lee 無
- Mu-Hsin Chang 無
- Ming-Huang Chen 無
- Ta-Chung Chao 無
- Jiun-I Lai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ying-Chun Shen 無
- 徐偉勛 無
- 吳宗哲 無
- Chiun Hsu 無
- Jih-Hsiang Lee 無
- Chih-Hung Hsu 無
- 呂理駿 無
- YU-YUN SHAO 無
- TSUNG-HAO LIU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
100 participants
